NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

A Cure for Crime? Psycho-Pharmaceuticals and Crime Trends

Dave E. Marcotte, Sara Markowitz

NBER Working Paper No. 15354
Issued in September 2009
NBER Program(s):   HE   LE   PE

In this paper we consider possible links between the advent and diffusion of a number of new psychiatric pharmaceutical therapies and crime rates. We describe recent trends in crime and review the evidence showing mental illness as a clear risk factor both for criminal behavior and victimization. We then briefly summarize the development of a number of new pharmaceutical therapies for the treatment of mental illness which diffused during the "great American crime decline." We examine limited international data, as well as more detailed American data to assess the relationship between crime rates and rates of prescriptions of the main categories of psychotropic drugs, while controlling for other factors which may explain trends in crime rates. We find that increases in prescriptions for psychiatric drugs are associated with decreases in violent crime, with the largest impacts associated with new generation antidepressants and stimulants used to treat ADHD.

download in pdf format
   (255 K)

email paper

The NBER Bulletin on Aging and Health provides summaries of publications like this.  You can sign up to receive the NBER Bulletin on Aging and Health by email.

This paper is available as PDF (255 K) or via email.

This paper was revised on December 5, 2011

Machine-readable bibliographic record - MARC, RIS, BibTeX

Document Object Identifier (DOI): 10.3386/w15354

Published: Dave E. Marcotte & Sara Markowitz, 2011. "A cure for crime? Psycho‚Äźpharmaceuticals and crime trends," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 30(1), pages 29-56, December. citation courtesy of

Users who downloaded this paper also downloaded these:
Frank and McGuire w15858 Mental Health Treatment and Criminal Justice Outcomes
David, Markowitz, and Richards-Shubik w14634 The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation
Kelly and Markowitz w13113 Incentives in Obesity and Health Insurance
Goldfarb, Leonard, Markowitz, and Suranovic w14838 Can A Rational Choice Framework Make Sense of Anorexia Nervosa?
Kim and Ruhm w15364 Inheritances, Health and Death
 
Publications
Activities
Meetings
NBER Videos
Data
People
About

Support
National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us